BIOR Stock - Biora Therapeutics, Inc.
Unlock GoAI Insights for BIOR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $4,000 | $305,000 | $1.25M | $74.31M | $143.99M |
| Gross Profit | $4,000 | $305,000 | $1.25M | $-19,120,000 | $43.49M |
| Gross Margin | 100.0% | 100.0% | 100.0% | -25.7% | 30.2% |
| Operating Income | $-67,143,000 | $-61,781,000 | $-117,837,000 | $-107,619,000 | $-140,119,000 |
| Net Income | $-124,115,000 | $-38,157,000 | $-178,521,000 | $-192,528,000 | $-148,037,000 |
| Net Margin | -3102875.0% | -12510.5% | -14316.0% | -259.1% | -102.8% |
| EPS | $-78.70 | $-6.40 | $-46.42 | $-86.30 | $-80.17 |
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
Visit WebsiteEarnings History & Surprises
BIOREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 12, 2025 | — | — | — | — |
Q3 2025 | Aug 15, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q1 2025 | Mar 25, 2025 | $-3.30 | — | — | — |
Q4 2024 | Nov 14, 2024 | $-3.85 | $-6.08 | -57.9% | ✗ MISS |
Q3 2024 | Aug 12, 2024 | $-4.50 | $-3.50 | +22.2% | ✓ BEAT |
Q2 2024 | May 15, 2024 | $-4.50 | $-6.10 | -35.6% | ✗ MISS |
Q1 2024 | Mar 26, 2024 | $-6.00 | $-6.30 | -5.0% | ✗ MISS |
Q4 2023 | Nov 13, 2023 | $-9.30 | $-7.50 | +19.4% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-16.00 | $-14.70 | +8.1% | ✓ BEAT |
Q2 2023 | May 15, 2023 | $-1.75 | $-15.90 | -808.6% | ✗ MISS |
Q1 2023 | Mar 30, 2023 | $-8.90 | $-16.10 | -80.9% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-15.00 | $-20.00 | -33.3% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $-32.50 | $-7.50 | +76.9% | ✓ BEAT |
Q2 2022 | May 10, 2022 | $-30.00 | $-30.00 | 0.0% | = MET |
Q1 2022 | Mar 28, 2022 | $-4.00 | $-14.00 | -250.0% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | $-11.17 | $-11.50 | -3.0% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $-20.17 | $-16.25 | +19.4% | ✓ BEAT |
Q2 2021 | May 13, 2021 | $-20.30 | $-14.00 | +31.0% | ✓ BEAT |
Q1 2021 | Mar 18, 2021 | $-20.55 | $-38.25 | -86.1% | ✗ MISS |
Latest News
Frequently Asked Questions about BIOR
What is BIOR's current stock price?
What is the analyst price target for BIOR?
What sector is Biora Therapeutics, Inc. in?
What is BIOR's market cap?
Does BIOR pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BIOR for comparison